Prognostic and effect predictive factors of multimodality treatment for gastric cancer

Prognostic and effect predictive factors of multimodality treatment for gastric cancer - Prognostic and effect predictive factors of multimodality treatment for gastric cancer

Status

Recruiting

Phases

Phase 2

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000031060

Enrollment

500

Registered

2018-02-20

Start date

2018-02-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Gastric cancer

Exclusion criteria

Exclusion criteria: Patients with poorer prognosis less than three months. Patients who decline the offer to use the data

Design outcomes

Primary

Measure	Time frame
Overall survival	—

Secondary

Measure	Time frame
Recurrence rate Progression free survival Overall objective response rate Side effects of chemotherapy perioperative complication	—

Countries

Japan,South America

Contacts

Public ContactMasazumi Takahashi

Yokohama Municipal Citizen's Hospital Division of Gastroenterological Surgery

ma06-takahashi@city.yokohama.jp045-331-1961

Outcome results